Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Xeros Technology Group Plc | LSE:XSG | London | Ordinary Share | GB00BMGYBJ57 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.425 | 136 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.40 | 0.45 | 0.425 | 0.425 | 0.425 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Industrial Patterns | 297k | -4.26M | -0.0082 | -0.51 | 2.21M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:02:20 | O | 136 | 0.40 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/10/2024 | 09:27 | UK RNS | Xeros Technology Group plc Holding(s) in Company |
| 15/10/2024 | 15:22 | UK RNS | Xeros Technology Group plc Holding(s) in Company |
| 30/9/2024 | 06:00 | UK RNS | Xeros Technology Group plc Interim Results 2024 |
| 19/9/2024 | 06:00 | UK RNS | Xeros Technology Group plc Notice of Results and Online Presentation |
| 06/9/2024 | 10:11 | UK RNS | Xeros Technology Group plc TR-1 |
| 05/9/2024 | 18:44 | ALNC |  IN BRIEF: Xeros Technology falls as reduces revenue expectations |
| 05/9/2024 | 06:00 | UK RNS | Xeros Technology Group plc Filtration Licence Agreement with Donlim Group |
| 05/9/2024 | 06:00 | UK RNS | Xeros Technology Group plc Trading Update |
| 22/7/2024 | 13:28 | UK RNS | Xeros Technology Group plc TR-1 |
| 22/7/2024 | 13:25 | UK RNS | Xeros Technology Group plc TR-1 |
Xeros Technology (XSG) Share Charts1 Year Xeros Technology Chart |
|
1 Month Xeros Technology Chart |
Intraday Xeros Technology Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 30/9/2024 | 13:01 | Xeros Technology Group plc | 3,474 |
| 04/2/2020 | 10:38 | Xeros Technology Group PLC | 35 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:02:21 | 0.40 | 136 | 0.54 | O |
| 2024-11-20 16:00:37 | 0.43 | 2,500,000 | 10,625.00 | O |
| 2024-11-20 15:58:52 | 0.40 | 250,000 | 1,000.00 | O |
| 2024-11-20 14:49:09 | 0.40 | 500,000 | 2,000.00 | O |
| 2024-11-20 14:48:48 | 0.40 | 100,000 | 400.00 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Xeros Technology Daily Update Xeros Technology Group Plc is listed in the Industrial Patterns sector of the London Stock Exchange with ticker XSG. The last closing price for Xeros Technology was 0.43p.Xeros Technology currently has 520,686,413 shares in issue. The market capitalisation of Xeros Technology is £2,186,883. Xeros Technology has a price to earnings ratio (PE ratio) of -0.51. This morning XSG shares opened at 0.43p |
Posted at 30/9/2024 11:30 by wheeze 11,250,000 trade gone through with no price movement. Anyone got a clue whats going on ? |
Posted at 05/9/2024 08:18 by slicethepie Looking at their share register a lot of well known investors getting this one wrong big time! |
Posted at 05/9/2024 06:52 by timbo003 Cavendish comment following today's announcements:Xeros (XSG): CORP New licence announced, lower near-term expectations The group’s trading update signals a delay to near-term revenues and a new licence signed with Donlim Group. The previously expected uptake of its Care product with IFB, its Indian partner, has been delayed into 2025. New standards on the environmental impact of microplastics from legislation in France have yet to be clarified and as such will not boost short-term demand for its XF3 microfibre filtration product. The group outlines lower short-term expectations, and we adjust forecasts with our FY24E pretax loss increasing by £1.6m to £4.3m and a FY25E pre-tax loss of £1.0m, previously a profit of £1.3m. Net cash was £4.0m on 30 August, with FY24 cash expected at £2.9m. The Board expects to have sufficient cash resource to see the company through until it achieves net monthly cash breakeven during the latter part of FY25. On lower near-term forecasts, we reduce our TP from 18p to 16p, although the longer-term market opportunity and the environmental benefits of its technology remain significant. |
Posted at 06/4/2024 11:30 by wheeze Thanks slicethepie - you are correct there. Which leaves the question, who has bitten off a big chunk of the company? They have promised to break even in FY2 2024, so presumably anticipated revenues are sizeable. The conspiracy theorist in me thinks this is giving some party behind a massive short a way out. I am deeply distrustful of the AIM market having witnessed so much shenanigans over the years. The question is if they are expecting to break even in FY2, why raise so much capital at this late stage giving away such a big chunk at an all time low share price? Any thoughts? |
Posted at 28/2/2024 12:03 by timbo003 The bid price is now below the price paid by the warrant holders (like myself) at the end of January ☹️The question I have now, is with the cash in from the warrants, will the company have enough cash runway to get to cash breakeven without another raise? |
Posted at 30/1/2024 11:17 by timbo003 I have now opted to exercise my warrants from the last placing @ 2.85p/shareWith a 15% discount to the current bid price and with an increasing likleyhood that the company will not require another fund raise to reach breakeven (due to warrants getting exercised), exercising the warrants and holding the acquired shares until the company reaches cash breakeven (or beyond), seems like a sensible strategy to me. |
Posted at 30/1/2024 10:57 by timbo003 Last broker comment (29 November 2023)XEROS (XSG): CORP On track for FY23E EBITDA and cash; consulting on warrants Xeros has published a trading update confirming FY23E adj. EBITDA and year-end cash are expected to meet our forecasts of -£4.7m and £1.6m respectively. The revenue outturn is partly dependent on the timing of an XOrb shipment delivery to a licence partner. In the event this shipment is delivered in FY23E, we would expect a modest beat at the adj. EBITDA level. Xeros has also announced it is exploring the possibility of amending the terms of warrants, which could further bolster its cash position. We make no changes to our forecasts at this stage and continue to expect month-on-month adj. EBITDA and cash breakeven towards the end of FY24E. We reiterate our 18p/share target price. |
Posted at 26/1/2024 08:38 by wheeze I would suggest anyone who believes this is worth zero, mortgage your house if you have one and go short. Significant number of RNSd licensing agreements due to deliver soon. Go through them individually. I have. It is significant that massive selling did not drop the share price. I believe Spreadex was shorting Xeros and may have now cleared their positions. DYOR as I may be wrong. I have added yesterday. |
Posted at 09/1/2024 16:00 by timbo003 >>>wheeze, I will hazard a guess that it is to do with Spreadex participation in the last placing (at 5p/share back in Sept 22), each share came with a warrant which placees can now exercise at 2.85p/share until the end of January. I took part in the Sept 2022 placing and will exercise my warrants at 2.85p assuming the share price remains where it is (or higher). I expect others (including Speeadex and their clients) will do the same, in which case there may be some forward selling by Spreadex and/or their clients up until when the new shares are issued at the end of Jan/beginning of Feb |
Posted at 17/10/2023 09:41 by jpuff Maybe they should produce a flyer for shareholders explaining how the share price has fallen from thirty quid to two pence. Now that would be an interesting read rather than the pish I won't even bother with below. And how much have the board of directors paid themselves in the meantime for such a monumental achievement for their shareholder owners? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
